SCHEMBL618825

SCHEMBL618825

N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)c(CS(=O)(=O)O)c1CS(=O)(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 1/20 0.50
F12 P00748 12/20 0.45
PRSS1 P07477 7/20 0.45
F2 P00734 6/20 0.45
PLG P00747 6/20 0.45
F10 P00742 3/20 0.45
C1R P00736 2/20 0.45
KLK1 P06870 2/20 0.45
TMPRSS2 O15393 1/20 0.45
MLNR O43193 1/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
ITGB3 P05106 1/20 0.45
HPN P05981 1/20 0.45
CHRM2 P08172 1/20 0.45
ITGA2B P08514 1/20 0.45
C1S P09871 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
MAPT P10636 1/20 0.45
CHRM1 P11229 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10698009 0.79 FTO (0.59) FTOF12PRSS1F2PLG
SCHEMBL7341905 0.77 F12 (0.57) FTOF12PRSS1F2PLG
SCHEMBL7336993 0.77 FTO (0.62) FTOF12PRSS1F2PLG
Nafamostat SCHEMBL29832433 0.74 FTO (0.70) FTOF12PRSS1F2PLG
Nafamostat SCHEMBL564665 0.74 FTO (0.70) FTOF12PRSS1F2PLG
Nafamostat SCHEMBL874941 0.74 FTO (0.64) FTOF12PRSS1F2PLG
SCHEMBL7340854 0.74 F12 (0.55) FTOF12PRSS1F2PLG
Nafamostat SCHEMBL1568755 0.74 FTO (0.70) FTOF12PRSS1F2PLG
SCHEMBL7350024 0.73 FTO (0.62) FTOF12PRSS1F2PLG
SCHEMBL7341009 0.72 F12 (0.50) FTOF12PRSS1F2PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8790885-B2 Coagulogen raw material, process for producing the same, and method and apparatus for measuring physiologically active substance of biological origin using the same KOWA COMPANY, LTD. (JP) 2014-07-29 US disclosed
US-8211651-B2 Method for measuring endotoxin and reagent kit for measuring endotoxin KOWA COMPANY, LTD. (JP) 2012-07-03 US disclosed
US-20120040385-A1 COAGULOGEN RAW MATERIAL, PROCESS FOR PRODUCING THE SAME, AND METHOD AND APPARATUS FOR MEASURING PHYSIOLOGICALLY ACTIVE SUBSTANCE OF BIOLOGICAL ORIGIN USING THE SAME KOWA COMPANY, LTD. (JP) 2012-02-16 US disclosed
US-20110201015-A1 METHOD FOR MEASURING ENDOTOXIN AND REAGENT KIT FOR MEASURING ENDOTOXIN KOWA COMPANY, LTD. (JP) 2011-08-18 US disclosed
EP-2233927-A1 METHOD FOR MEASURING ENDOTOXIN AND REAGENT KIT FOR MEASURING ENDOTOXIN Kowa Company, Ltd. (JP) 2010-09-29 EP disclosed
EP-0765339-A1 3-AMINO-2-OXO-1-PIPERIDINEACETIC DERIVATIVES CONTAINING AN ARGININE MIMIC AS ENZYME INHIBITORS CORVAS INTERNATIONAL, INC. (US) 1997-04-02 EP disclosed
WO-1995035313-A1 3-AMINO-2-OXO-1-PIPERIDINEACETIC DERIVATIVES CONTAINING AN ARGININE MIMIC AS ENZYME INHIBITORS CORVAS INTERNATIONAL, INC. (US) 1995-12-28 WO disclosed
US-5238964-A P-Guanidinobenzoic acid derivatives TORII & CO., LTD. (JP) 1993-08-24 US disclosed